A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adults With Attention-Deficit/Hyperactivity Disorder

Attention Deficit ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Amphetamine Sulfate

Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial

Advances in Integrative Medicine ◽

10.1016/j.aimed.2022.01.002 ◽

2022 ◽

Author(s):

Benyamin Pazoki ◽

Nadia Zandi ◽

Zeinab Assaf ◽

Hossein Sanjari Moghaddam ◽

Arefeh Zeinoddini ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

Neuropsychiatric Disease and Treatment ◽

10.2147/ndt.s206020 ◽

2019 ◽

Vol Volume 15 ◽

pp. 1193-1209 ◽

Cited By ~ 4

Author(s):

Celestino Rodíguez ◽

Trinidad Garcia ◽

Debora Areces ◽

Estrella Fernández ◽

Marcelino García-Noriega ◽

...

Keyword(s):

Docosahexaenoic Acid ◽

Attention Deficit ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy and safety of tipepidine as adjunctive therapy in children with attention‐deficit/hyperactivity disorder: Randomized, double‐blind, placebo‐controlled clinical trial

Psychiatry and Clinical Neurosciences ◽

10.1111/pcn.12913 ◽

2019 ◽

Vol 73 (11) ◽

pp. 690-696 ◽

Cited By ~ 5

Author(s):

Sara Dehbozorghi ◽

Sayna Bagheri ◽

Kamyar Moradi ◽

Kamyar Shokraee ◽

Mohammad‐Reza Mohammadi ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

The World Journal of Biological Psychiatry ◽

10.3109/15622975.2011.600333 ◽

2011 ◽

Vol 14 (4) ◽

pp. 268-281 ◽

Cited By ~ 9

Author(s):

Miguel Casas ◽

Michael Rösler ◽

J. J. Sandra Kooij ◽

Ylva Ginsberg ◽

Josep Antoni Ramos-Quiroga ◽

...

Keyword(s):

Attention Deficit ◽

Fixed Dose ◽

Prolonged Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Dose Study

A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder

Journal of Developmental & Behavioral Pediatrics ◽

10.1097/00004703-200208000-00022 ◽

2002 ◽

Vol 23 (4) ◽

pp. 286

Author(s):

ADRIAN D. SANDLER

Keyword(s):

Docosahexaenoic Acid ◽

Attention Deficit ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Acid Supplementation ◽

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

Behavioral and Brain Functions ◽

10.1186/1744-9081-6-34 ◽

2010 ◽

Vol 6 (1) ◽

pp. 34 ◽

Cited By ~ 86

Author(s):

Timothy Wigal ◽

Matthew Brams ◽

Maria Gasior ◽

Joseph Gao ◽

Liza Squires ◽

...

Keyword(s):

Crossover Study ◽

Attention Deficit ◽

Environment Design ◽

Efficacy And Safety ◽

Lisdexamfetamine Dimesylate ◽

Double Blind ◽

Workplace Environment ◽

Double Blind Placebo ◽

Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial

Advances in Therapy ◽

10.1007/s12325-013-0085-5 ◽

2013 ◽

Vol 31 (1) ◽

pp. 44-65 ◽

Cited By ~ 19

Author(s):

Michael Huss ◽

Ylva Ginsberg ◽

Torbjorn Tvedten ◽

Torben Arngrim ◽

Alexandra Philipsen ◽

...

Keyword(s):

Attention Deficit ◽

Controlled Trial ◽

Modified Release ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: A 4-week, randomized, double-blind, placebo-controlled, parallel-group study

Clinical Therapeutics ◽

10.1016/j.clinthera.2006.02.011 ◽

2006 ◽

Vol 28 (2) ◽

pp. 266-279 ◽

Cited By ~ 64

Author(s):

Thomas J. Spencer ◽

Timothy E. Wilens ◽

Joseph Biederman ◽

Richard H. Weisler ◽

Stephanie C. Read ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Parallel Group Study ◽

Parallel Group ◽

Adolescent Patients

Pharmacotherapy of Attention Deficit Hyperactivity Disorder in Children: Results of a Multicenter, Double-Blind, Placebo-Controlled Trial of Hopantenic Acid

Neuroscience and Behavioral Physiology ◽

10.1007/s11055-018-0705-2 ◽

2018 ◽

Vol 49 (1) ◽

pp. 129-135 ◽

Cited By ~ 1

Author(s):

N. N. Zavadenko ◽

N. Yu. Suvorinova ◽

I. N. Vakula ◽

E. V. Malinina ◽

L. M. Kuzenkova

Keyword(s):

Attention Deficit ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

A Double-Blind, Placebo-Controlled Trial of Dexmethylphenidate Hydrochloride and d,l-threo-Methylphenidate Hydrochloride in Children With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1097/01.chi.0000138351.98604.92 ◽

2004 ◽

Vol 43 (11) ◽

pp. 1406-1414 ◽

Cited By ~ 71

Author(s):

SHARON WIGAL ◽

JAMES M. SWANSON ◽

DAVID FEIFEL ◽

R BART SANGAL ◽

JOSEPHINE ELIA ◽

...

Keyword(s):

Attention Deficit ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽